摘要 |
The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and a pharmaceutically acceptable carrier. The invention also provides a pharmaceutical composition comprising an effective amount of at least one compound of Formula (I) and an effective amount of at least one other pharmaceutically active ingredient (such as, for example, a chemotherapeutic agent), and a pharmaceutically acceptable carrier. |
申请人 |
MERCK SHARP & DOHME CORP.;SILIPHAIVANH, PHIENG;METHOT, JOEY;LIPFORD, KATHRYN ANN;MOLINARI, DANIELLE;SLOMAN, DAVID, L.;WITTER, DAVID;ZHOU, HUA;BOYCE, CHRISTOPHER;HUANG, XIANHAI;LIM, JONGWON;GUERIN, DAVID;KARUNAKARAN, GANESH BABU;BAKSHI, RAMAN KUMAR;LIU, ZIPING;FU, JIANMIN;WAN, ZHILONG;LIU, WEI |
发明人 |
SILIPHAIVANH, PHIENG;METHOT, JOEY;LIPFORD, KATHRYN ANN;MOLINARI, DANIELLE;SLOMAN, DAVID, L.;WITTER, DAVID;ZHOU, HUA;BOYCE, CHRISTOPHER;HUANG, XIANHAI;LIM, JONGWON;GUERIN, DAVID;KARUNAKARAN, GANESH BABU;BAKSHI, RAMAN KUMAR;LIU, ZIPING;FU, JIANMIN;WAN, ZHILONG;LIU, WEI |